Is there any interaction between Adderall (mixed amphetamine salts) and omeprazole?

Adderall and Omeprazole Interaction

Omeprazole can alter the absorption kinetics of Adderall (mixed amphetamine salts), potentially causing earlier and less predictable drug release, though total drug exposure remains unchanged.

Mechanism of Interaction

Omeprazole, as a proton pump inhibitor (PPI), increases gastric pH by reducing stomach acid production. This pH change can affect the dissolution and absorption of pH-dependent drug formulations like extended-release amphetamine preparations 1.

Clinical Impact

The interaction manifests differently depending on the Adderall formulation:

For Extended-Release Formulations:

• Approximately 50-60% of patients experience earlier peak drug levels (Tmax) when taking omeprazole with extended-release mixed amphetamine salts 1
• The median time to peak concentration shifts from 5 hours to 2.75 hours with omeprazole co-administration 1
• This occurs because reduced stomach acid compromises the controlled-release mechanism of the second bead in extended-release formulations, leading to unpredictable drug release 1

Total Drug Exposure:

• The overall amount of amphetamine absorbed (AUC and Cmax) remains essentially unchanged 1
• Mean Cmax: 36.6 ng/mL without omeprazole vs 38.1 ng/mL with omeprazole 1
• Mean AUC: 640.8 ng·h/mL without omeprazole vs 643.9 ng·h/mL with omeprazole 1

Clinical Significance

While this interaction does not constitute a contraindication or major safety concern, the altered pharmacokinetics can affect:

• Symptom control timing: Earlier peak may provide faster symptom relief but shorter duration of action
• Side effect profile: Earlier, higher peaks may transiently increase cardiovascular effects (increased blood pressure, heart rate) or CNS stimulation 2
• Dosing predictability: The inconsistent release pattern makes therapeutic optimization more challenging

Management Recommendations

Monitor for:

• Changes in ADHD symptom control duration throughout the day
• Earlier onset of stimulant effects or side effects (jitteriness, appetite suppression, cardiovascular symptoms)
• Need for dosing adjustments or timing modifications

Consider:

• Switching to immediate-release formulations if extended-release becomes unpredictable
• Adjusting Adderall dosing schedule if symptom coverage becomes inadequate
• Evaluating whether omeprazole is still indicated, as prolonged PPI use should be periodically reassessed 3

Cardiovascular Monitoring: Regular blood pressure and heart rate monitoring remains essential when prescribing Adderall, regardless of omeprazole co-administration 4, 2.

Important Caveats

This interaction is pharmacokinetic, not pharmacodynamic—it affects drug delivery timing but not the fundamental mechanism of action or total drug exposure. The FDA labeling for omeprazole notes it can alter systemic exposure of drugs with pH-dependent solubility 5, but this does not rise to the level of requiring dose adjustment or contraindication for amphetamines.

The clinical relevance is primarily about predictability of therapeutic effect rather than safety concerns, though individual patients may experience more pronounced effects from the altered absorption pattern.